Literature DB >> 21071700

Regulation of platelet function by class B scavenger receptors in hyperlipidemia.

Alejandro Zimman1, Eugene A Podrez.   

Abstract

Platelets constitutively express class B scavenger receptors CD36 and SR-BI, 2 closely related pattern recognition receptors best known for their roles in lipoprotein and lipid metabolism. The biological role of scavenger receptors in platelets is poorly understood. However, in vitro and in vivo data suggest that class B scavenger receptors modulate platelet function and contribute significantly to thrombosis by sensing pathological or physiological ligands, inducing prothrombotic signaling, and increasing platelet reactivity. Platelet CD36 recognizes a novel family of endogenous oxidized choline phospholipids that accumulate in plasma of hyperlipidemic mice and in plasma of subjects with low high-density lipoprotein levels. This interaction leads to the activation of specific signaling pathways and promotes platelet activation and thrombosis. Platelet SR-BI, on the other hand, plays a critical role in the induction of platelet hyperreactivity and accelerated thrombosis under conditions associated with increased platelet cholesterol content. Intriguingly, oxidized high-density lipoprotein, an SR-BI ligand, can suppress platelet function. These recent findings demonstrate that platelet class B scavenger receptors play roles in thrombosis in dyslipidemia and may contribute to acute cardiovascular events in vivo in hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071700      PMCID: PMC3000313          DOI: 10.1161/ATVBAHA.110.207498

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  97 in total

1.  Platelet function in hyperlipoproteinemia.

Authors:  A C Carvalho; R W Colman; R S Lees
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

2.  Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.

Authors:  Katrin Schafer; Katja Müller; Anneke Hecke; Emmanuelle Mounier; Julia Goebel; David J Loskutoff; Stavros Konstantinides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-25       Impact factor: 8.311

3.  Platelet hypersensitivity induced by cholesterol incorporation.

Authors:  S J Shattil; R Anaya-Galindo; J Bennett; R W Colman; R A Cooper
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

4.  [Enhancement of platelet function in cholesterol-fed guinea-pigs].

Authors:  J Maeda; T Tsuboi; B Fujitani; T Kadokawa; M Shimizu
Journal:  Nihon Yakurigaku Zasshi       Date:  1982-08

Review 5.  The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues.

Authors:  Attilio Rigotti; Helena E Miettinen; Monty Krieger
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

6.  Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the framingham study.

Authors:  Doreen Osgood; Dolores Corella; Serkalem Demissie; L Adrienne Cupples; Peter W F Wilson; James B Meigs; Ernst J Schaefer; Oscar Coltell; Jose M Ordovas
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

Review 7.  Antiplatelet therapy in peripheral arterial disease.

Authors:  Wilbert S Aronow
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2004-09

8.  Effect of cholesterol on production of thromboxane b2 by platelets in vitro.

Authors:  M J Stuart; J M Gerrard; J G White
Journal:  N Engl J Med       Date:  1980-01-03       Impact factor: 91.245

9.  Population-based study of SR-BI genetic variation and lipid profile.

Authors:  Alfredo Morabia; Barbara M Ross; Michael C Costanza; Eftihia Cayanis; Maria Sol Flaherty; Gabriela B Alvin; Kamna Das; Richard James; An-Suei Yang; Oleg Evagrafov; T Conrad Gilliam
Journal:  Atherosclerosis       Date:  2004-07       Impact factor: 5.162

10.  CD36 mediates the innate host response to beta-amyloid.

Authors:  Joseph B El Khoury; Kathryn J Moore; Terry K Means; Josephine Leung; Kinya Terada; Michelle Toft; Mason W Freeman; Andrew D Luster
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

View more
  17 in total

1.  TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.

Authors:  Sudipta Biswas; Alejandro Zimman; Detao Gao; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2017-08-03       Impact factor: 17.367

Review 2.  Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.

Authors:  Wen-Jun Shen; Jie Hu; Zhigang Hu; Fredric B Kraemer; Salman Azhar
Journal:  Metabolism       Date:  2014-03-21       Impact factor: 8.694

3.  Platelet hyperreactivity: a new twist in old mice.

Authors:  Eugene A Podrez
Journal:  Blood       Date:  2019-08-29       Impact factor: 22.113

Review 4.  SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux.

Authors:  Wen-Jun Shen; Salman Azhar; Fredric B Kraemer
Journal:  Annu Rev Physiol       Date:  2017-11-10       Impact factor: 19.318

5.  Human platelets efficiently kill IgG-opsonized E. coli.

Authors:  Anum H Riaz; Brian E Tasma; Michael E Woodman; R Mark Wooten; Randall G Worth
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-20

6.  Novel phosphatidylethanolamine derivatives accumulate in circulation in hyperlipidemic ApoE-/- mice and activate platelets via TLR2.

Authors:  Sudipta Biswas; Liang Xin; Soumya Panigrahi; Alejandro Zimman; Hua Wang; Valentin P Yakubenko; Tatiana V Byzova; Robert G Salomon; Eugene A Podrez
Journal:  Blood       Date:  2016-03-25       Impact factor: 22.113

7.  Prothrombotic lipoprotein patterns in stroke.

Authors:  Eugene A Podrez; Tatiana V Byzova
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

8.  Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis.

Authors:  Soumya Panigrahi; Yi Ma; Li Hong; Detao Gao; Xiaoxia Z West; Robert G Salomon; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2012-10-15       Impact factor: 17.367

9.  Circulating CD36 is increased in hyperlipidemic mice: Cellular sources and triggers of release.

Authors:  Sudipta Biswas; Detao Gao; Jessica B Altemus; Umar R Rekhi; Ellen Chang; Maria Febbraio; Tatiana V Byzova; Eugene A Podrez
Journal:  Free Radic Biol Med       Date:  2021-03-26       Impact factor: 7.376

10.  Possible regulation of platelets by native and modified low density lipoprotein-cholesterol particles.

Authors:  Ki Hoon Han
Journal:  Korean Circ J       Date:  2012-08-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.